Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
9 participants
INTERVENTIONAL
2019-10-07
2022-02-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
His Bundle Recording From Subclavian Vein
NCT04115735
Left Bundle Branch Pacing Versus Conventional Pacing in Atrioventricular Block
NCT05129098
Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundle Branch Block
NCT03803995
Left Bundle Branch Pacing Versus Right Ventricular Pacing in Patients With Atrioventricular Block
NCT05722379
Left vs Left Randomized Clinical Trial
NCT05650658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients requiring pacemaker implant will be screened for study eligibility and approached for informed consent. Baseline assessments including echocardiogram and ECG will be obtained. A standard of care echo done within 3 months of the procedure will be used as the baseline echo. Once enrolled, the researchers will randomize patients to one of two arms. One arm will fixate the ventricular pacemaker lead to the HIS bundle area while the other arm will have the leads fixed into the left bundle area. The pacemaker wires will be connected in accordance with randomization group. The day after the procedure, a chest x-ray, EKG and pacemaker evaluation will be performed. An echocardiogram will be obtained at 3 months post procedure. At 6 and 12 months post procedure, EKG rhythm strips will be obtained from patients' standard of care remote pacemaker monitoring systems.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Selective or Non selective His Bundle Pacing
Pacemaker wires placed in Bundle of His
Select Secure pacing lead
A Select Secure pacing lead is placed in the bundle of His or Left bundle branch area based upon randomization
Left Bundle Area Pacing
Pacemaker wires placed in Left Bundle Branch area
Select Secure pacing lead
A Select Secure pacing lead is placed in the bundle of His or Left bundle branch area based upon randomization
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Select Secure pacing lead
A Select Secure pacing lead is placed in the bundle of His or Left bundle branch area based upon randomization
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. With signed consent.
3. Pacemaker indication according to 2018 American College of Cardiology/American Heart Association/Heart Rhythm Society Guideline on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay. With one or both of the following:
1. Symptomatic sinus node dysfunction.
2. Symptomatic Atrioventricular (AV) block or high degree AV block.
3. Tachy-Brady syndrome
Exclusion Criteria
2. Patients who are eligible for appropriate cardiac resynchronization therapy(CRT) or implantable cardiovert defibrillator (ICD) implantation
3. Patients with prior septal myectomy
4. Patients with prior surgical or transcatheter aortic valve replacement
5. Anatomy precluding implant evaluated during the screening or identified during the procedure.
6. Those without ability to achieve selective His bundle pacing evaluated during the screening or identified during the procedure
7. Pregnant women
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
David Haines, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Haines, MD
Director, Electrophysiology and Heart Rhythm Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Haines, MD
Role: PRINCIPAL_INVESTIGATOR
Beaumont
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beaumont Health System
Royal Oak, Michigan, United States
Beaumont Health System
Troy, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-191
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.